MXCT vs NI · rev $38.6M vs P/E 23, rev $5.28B
MaxCyte Inc (MXCT) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported NI revenue for 2024-12-31 was $5.28B. Net income was $844.7M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. NI currently screens at market cap $22.42B and trailing P/E 23.3.
MXCT currently screens at market cap $124.3M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the MXCT and NI stock pages for the full models.
Not investment advice.